Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 165 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Joins WHO Global Clinical Trials Forum to Strengthen Global Oncology Research Ecosystems EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom Responses Over Ruxolitinib in Patients with JAK Inhibitor-Naïve Myelofibrosis MOST POPULAR EMA Recommends Extension of Therapeutic Indications for Tisagenlecleucel May 4, 2022 Young Woman’s Breast Cancer Diagnosis Ends Up Saving Her Mom’s Life... September 27, 2021 Breast Cancer Survivor Says Mistletoe Injections Have Kept Her Cancer-Free For... December 9, 2019 EMA Issues Direct Healthcare Professional Communications for Crizotinib-Related Vision Disorders in... June 24, 2022 Load more HOT NEWS A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly... 2023 Highlights in Treating Genitourinary Cancers: Expert Perspectives How cancer hijacks cell death: a new view of metastasis Reflections
